NASDAQ · RMTIHealthcarePharmaceuticals

Rockwell Medical, Inc. (DE) Common Stock (RMTI)

$8.05−0.49%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$8.05▼ 22.60% in range
Nov 4, 2025Low $5.19 · High $55.05Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Rockwell Medical, Inc. (DE) closed at $8.05 on Nov 4, down 0.49%, 85.4% below its 52-week closing high. Volume of 17.3K shares was 0.58× its 20-day average (below normal).

Split-adjusted performance: +5.2% over one month, -0.6% over six months, -25.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $17.78M, up 10.6% from a year earlier, with a net margin of -7.5%.

Short interest was 70.1K shares at the Oct 15 settlement, down 1.0% from the prior report (2.0% of float, 2.2 days to cover).

Market cap$32.4M4.0M shares
Revenue · quarter$17.8M+10.6% YoY
Diluted EPS$-0.34—
P/E · TTM—P/S 0.5×
Net margin-7.5%Gross 18.2%
Dividend yieldNone
52-week range5.19 – 55.05−85.4% from high
Volume17.3K0.58× 20-day avg
Volatility · 60d59.8%Annualised
Short % of float2.0%2.2 days to cover
Net cash$15.3MCash $24.8M
Next earnings—Not scheduled
Split-adjusted performance
1W +10.1%1M +5.2%3M +12.4%6M −0.6%YTD −3.4%1Y −25.5%3Y −52.4%5Y −86.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum71
Revenue growth57
Net margin65
Value (low P/E)—
Size26

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short70.1K−1.0% vs prior
Days to cover2.2Settled Oct 15
% of float2.0%
Short vol. 10d35.3%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
RMTIRockwell Medical, Inc. (DE)$8.05−0.49%−0.6%+10.6%−7.5%—$32.4M
LITSLite Strategy$1.08+3.85%−9.2%———$32.8MCompare
PMNProMIS Neurosciences Inc. Common Shares (ON)$3.52+3.23%−68.0%———$31.6MCompare
IXHLIncannex Healthcare Limited$2.49−0.60%−49.3%———$31.2MCompare
IBOImpact BioMedical$4.10+1.99%−48.8%−57.1%−23300.0%44.4$35.0MCompare
NNVCNanoViricides$1.38−3.50%−5.5%———$35.2MCompare
BTMDBiote$1.23+9.82%−44.1%−9.5%−14.8%6.0$35.3MCompare
ACETAdicet Bio$3.10−2.21%−63.7%———$29.0MCompare
VERUVeru$2.20+1.85%−0.9%———$37.5MCompare

Quick answers

What does Rockwell Medical, Inc. (DE) do?
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States.
What is RMTI's market cap?
$32.45M, based on the Nov 4 close of $8.05.
Does Rockwell Medical, Inc. (DE) pay a dividend?
No regular cash dividend has been paid in the last year.
How much of RMTI is sold short?
70.1K shares, 2.0% of float, as of Oct 15, 2026.
What sector is RMTI in?
Healthcare, in the Pharmaceuticals industry.

About Rockwell Medical, Inc. (DE)

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

HQ: Wixom, MI157 employeesListed Jan 27, 1998rockwellmed.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology